Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.

PURPOSE Exposure to the microgravity environment of space increases the risk of kidney stone formation, particularly for calcium oxalate and uric acid stones. This study was performed to evaluate the efficacy of potassium alkali as potassium-magnesium citrate in reducing renal stone risk and bone turnover. MATERIALS AND METHODS This study was performed as a double-blind, placebo controlled trial. We studied 20 normocalciuric subjects randomized to either placebo or potassium-magnesium citrate (42 mEq potassium, 21 mEq magnesium, 63 mEq citrate per day) before and during 5 weeks of strict bed rest. The study was performed in the General Clinical Research Center and under a controlled dietary regimen composed of 100 mEq of sodium, 800 mg of calcium, 0.8 gm/kg animal protein and 2,200 kcal per day. Two 24-hour urine collections were obtained under oil each week for assessment of stone risk parameters and relative saturation of calcium oxalate, brushite and undissociated uric acid. Blood was also collected for determination of serum immunoreactive parathyroid hormone and vitamin D metabolites. RESULTS Bed rest promoted a rapid increase in urinary calcium excretion of approximately 50 mg per day in both groups. Despite this increase subjects treated with potassium-magnesium citrate demonstrated significant decreases in the relative saturation of calcium oxalate and in the concentration of undissociated uric acid compared to placebo. Immunoreactive parathyroid hormone, serum 1,25-dihydroxyvitamin D and intestinal calcium absorption all decreased in both groups with no difference in response between the 2 treatment arms. CONCLUSIONS Provision of alkali as potassium-magnesium citrate is an effective countermeasure for the increased risk of renal stone disease associated with immobilization. Despite an increase in urine calcium concentration, the relative saturation of calcium oxalate decreased due to citrate chelation of calcium and the concentration of undissociated uric acid decreased due to the significant increase in urine pH.

[1]  C. Pak,et al.  Physicochemical action of potassium‐magnesium citrate in nephrolithiasis , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Hiroshi Ohshima,et al.  Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90‐Day Bed Rest , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  J. Zerwekh,et al.  The Effects of Twelve Weeks of Bed Rest on Bone Histology, Biochemical Markers of Bone Turnover, and Calcium Homeostasis in Eleven Normal Subjects , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  R. Pietrzyk,et al.  Renal stone risk assessment during Space Shuttle flights. , 1997, The Journal of urology.

[5]  Scott M Smith,et al.  Bone Markers, Calcium Metabolism, and Calcium Kinetics During Extended‐Duration Space Flight on the Mir Space Station , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  A. Leblanc,et al.  Bone mineral loss and recovery after 17 weeks of bed rest , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  C. Pak,et al.  Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. , 1991, The Journal of urology.

[8]  Manoj Monga,et al.  Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure. , 2006, The Journal of urology.

[9]  Charles M. Brown,et al.  EQUIL2: a BASIC computer program for the calculation of urinary saturation. , 1985, The Journal of urology.

[10]  L. Smith,et al.  Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. , 1975, Investigative urology.

[11]  C. Pak,et al.  Effect of prolonged bedrest on the propensity for renal stone formation. , 1988, The Journal of clinical endocrinology and metabolism.

[12]  C. Pak,et al.  Prevention of hypercalciuria and stone‐forming propensity during prolonged bedrest by alendronate , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  R. Pietrzyk,et al.  Alterations in renal stone risk factors after space flight. , 1993, The Journal of urology.

[14]  M. Oh A new method for estimating G-I absorption of alkali. , 1989, Kidney international.

[15]  Peggy A. Whitson,et al.  The Risk of Renal Stone Formation during and after Long Duration Space Flight , 2001, Nephron.

[16]  S. Ljunghall,et al.  Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. , 1980, The Journal of urology.

[17]  C S Leach,et al.  Collagen cross-link excretion during space flight and bed rest. , 1998, The Journal of clinical endocrinology and metabolism.

[18]  Robert A Pietrzyk,et al.  Renal stone formation among astronauts. , 2007, Aviation, space, and environmental medicine.

[19]  C. Pak,et al.  The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers. , 1982, Contributions to nephrology.